This type 2 diabetes medication increases risk of grave dangers
Urgent insulin warning for every type 2 diabetic
One in every three.
That’s the shocking rate of type 2 diabetics who are at grave risk. And they don’t even know it.
But it’s not diabetes that increases their risk. Ironically, it’s their medication. And it’s potentially deadly.
That’s catastrophic news for millions who are using this drug. But there is a way to get off it and get back on track to better health.
Short-term success
Injectable insulin has extended countless lives of type 1 diabetics. But a new study shows that it can produce the exact opposite result for type 2 patients.
Researchers looked at long-term medical records of more than 84,000 type 2 diabetics.
Compared to using metformin…
* Insulin use increased risk of a major cardiac event, cancer, or early death by 80%
* Insulin use nearly doubled heart attack risk, and more than doubled neuropathy risk
Patients who took metformin and insulin together were still at greater risk of major cardiac event, cancer, or early death. But that risk was lower than when taking just insulin alone.
In type 1 diabetes, patients can’t produce their own insulin. In type 2 they can. So for these patients, an insulin injection is like a battering ram. Insulin is pumped up to such excess that it forces sugar into the cells.
So it works. In the short term. But as this new report shows, extended use of the battering ram technique should be avoided at all costs.
I think it’s safe to say that the vast majority of type 2 diabetics try to follow their doctors’ advice, overlooking the fact that they can manage their disease — and even reverse it without insulin or drug use.
Recently, I told you about type 2 diabetic Steve Cooksey. In the beginning, his condition was severe. But he dedicated himself to a strict non-carb diet. Within weeks, Steve brought his diabetes under control. Today, he doesn’t use any medications or insulin.
Now I realize that sounds tough but you might decide it’s worth it if you can avoid the needle and the Rx. Read more about how exactly he did it at this link.
Sources:
“Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes” The Journal of Clinical Endocrinology & Metabolism, Vol. 98, No. 2, February 2013, jcem.endojournals.org


